• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura.

作者信息

Mollica F, Li Volti S, Garozzo R, Russo G

机构信息

Department of Paediatrics, University of Catania, Italy.

出版信息

Eur J Pediatr. 1992 Feb;151(2):140-4. doi: 10.1007/BF01958961.

DOI:10.1007/BF01958961
PMID:1343079
Abstract

A prospective study was performed to verify whether early administration of prednisone could be useful in preventing the development of nephropathy in anaphylactoid purpura. Only patients without signs of nephropathy upon initial presentation entered into the study. A total of 84 patients received delta-prednisone (1 mg/kg per day per os for 2 weeks), and 84 patients did not receive steroids. The patients were followed for 24-36 months. None of the 84 patients treated with steroids and 10 (11.9%) of the 84 control patients developed nephropathy 2-6 weeks after the acute episode. In 2 other patients of the untreated group, signs of renal involvement appeared 2 and 6 years after the acute episode respectively. The difference in the prevalence of nephropathy between the two groups is highly significant (P less than 0.001).

摘要

相似文献

1
Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura.
Eur J Pediatr. 1992 Feb;151(2):140-4. doi: 10.1007/BF01958961.
2
Early prednisone treatment and nephropathy in anaphylactoid purpura.早期泼尼松治疗与过敏性紫癜性肾病
Eur J Pediatr. 1993 Sep;152(9):782-3. doi: 10.1007/BF01954006.
3
Incidence of renal complications in Schönlein-Henoch purpura syndrome in dependence of an early administration of steroids.
Int Urol Nephrol. 1988;20(4):409-12. doi: 10.1007/BF02549574.
4
[The effect of prednisone in the development of nephropathy in Schoenlein-Henoch purpura].
Cesk Pediatr. 1989 Mar;44(3):145-6.
5
Anaphylactoid purpura and renal disease: the case against routine steroids.类过敏性紫癜与肾脏疾病:反对常规使用类固醇的案例
Eur J Pediatr. 1993 Sep;152(9):782. doi: 10.1007/BF01954005.
6
Henoch-Schönlein purpura.亨诺-许兰紫癜
Am Fam Physician. 2009 Oct 1;80(7):697-704.
7
A randomized, placebo-controlled trial of prednisone in early Henoch Schönlein Purpura [ISRCTN85109383].一项关于泼尼松治疗早期过敏性紫癜的随机、安慰剂对照试验[国际标准随机对照试验编号:ISRCTN85109383]
BMC Med. 2004 Apr 2;2:7. doi: 10.1186/1741-7015-2-7.
8
Early prednisone therapy in Henoch-Schönlein purpura: a randomized, double-blind, placebo-controlled trial.过敏性紫癜的早期泼尼松治疗:一项随机、双盲、安慰剂对照试验
J Pediatr. 2006 Aug;149(2):241-7. doi: 10.1016/j.jpeds.2006.03.024.
9
Can the nephropathy in Schönlein-Henoch purpura (syndrome) be prevented by early administration of steroids?早期使用类固醇能否预防过敏性紫癜(综合征)中的肾病?
Clin Nephrol. 1987 Sep;28(3):156.
10
[Clinical study on integrative Chinese and Western medicine in treating allergic purpura and preventing renal impairment].中西医结合治疗过敏性紫癜及预防肾损害的临床研究
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004 Aug;24(8):701-3.

引用本文的文献

1
Guidelines for the diagnosis and management of childhood immunoglobulin A vasculitis.
World J Pediatr. 2025 Sep 26. doi: 10.1007/s12519-025-00974-8.
2
Antibiotic-induced IgA vasculitis: insights from a real-world retrospective analysis and pharmacovigilance assessment.抗生素诱导的IgA血管炎:来自真实世界回顾性分析和药物警戒评估的见解
Arch Dermatol Res. 2025 Feb 11;317(1):383. doi: 10.1007/s00403-025-03925-5.
3
Interventions for preventing and treating kidney disease in IgA vasculitis.用于预防和治疗 IgA 血管炎相关肾病的干预措施。

本文引用的文献

1
Circulating IgA-immune complexes in Henoch-Schönlein purpura. A longitudinal study of their relationship to disease activity and vascular deposition of IgA.过敏性紫癜中循环IgA免疫复合物:关于其与疾病活动及IgA血管沉积关系的纵向研究
Am J Med. 1980 Dec;69(6):859-66. doi: 10.1016/s0002-9343(80)80011-8.
2
IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases.疱疹样皮炎、过敏性紫癜、系统性红斑狼疮及其他疾病中含IgA的循环免疫复合物
Clin Exp Immunol. 1980 Jun;40(3):431-7.
3
Henoch-Schönlein nephritis: long-term prognosis of unselected patients.
Cochrane Database Syst Rev. 2023 Feb 28;2(2):CD005128. doi: 10.1002/14651858.CD005128.pub4.
4
Henoch-Schönlein purpura in children: Use of corticosteroids for prevention and treatment of renal disease.儿童过敏性紫癜:皮质类固醇在预防和治疗肾脏疾病中的应用。
Can Fam Physician. 2020 Dec;66(12):895-897. doi: 10.46747/cfp.6612895.
5
A retrospective analysis of children with Henoch-Schonlein purpura and re-evaluation of renal pathologies using Oxford classification.采用牛津分类法对过敏性紫癜患儿进行回顾性分析及肾脏病理再评估。
Clin Exp Nephrol. 2019 Jul;23(7):939-947. doi: 10.1007/s10157-019-01726-5. Epub 2019 Mar 20.
6
Ten-year Nationwide Population-based Survey on the Characteristics of Children with Henoch-Schӧnlein Purpura in Korea.韩国一项长达十年的全国基于人群的过敏性紫癜患儿特征调查
J Korean Med Sci. 2018 May 14;33(25):e174. doi: 10.3346/jkms.2018.33.e174. eCollection 2018 Jun 18.
7
Pulmonary Hemorrhaging as a Fatal Complication of IgA Vasculitis.肺出血作为IgA血管炎的致命并发症
Intern Med. 2018 Nov 1;57(21):3141-3147. doi: 10.2169/internalmedicine.0817-18. Epub 2018 Jun 6.
8
Mycophenolate mofetil plus prednisone for inducing remission of Henoch-Schönlein purpura nephritis: a retrospective study.霉酚酸酯联合泼尼松诱导紫癜性肾炎缓解:一项回顾性研究
J Zhejiang Univ Sci B. 2015 Sep;16(9):772-9. doi: 10.1631/jzus.B1400335.
9
Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP).过敏性紫癜(HSP)肾脏疾病的防治干预措施。
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD005128. doi: 10.1002/14651858.CD005128.pub3.
10
Henoch-Schönlein purpura in children: limited benefit of corticosteroids.儿童过敏性紫癜:皮质类固醇的疗效有限。
Can Fam Physician. 2014 Nov;60(11):1007-10.
过敏性紫癜肾炎:未经挑选患者的长期预后
Arch Dis Child. 1981 Jun;56(6):482-4. doi: 10.1136/adc.56.6.482.
4
Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schoenlein nephritis. Correlation with clinical and histologic signs of activity.原发性IgA肾病和过敏性紫癜性肾炎患者循环中含IgA、IgG和IgM的免疫复合物。与临床及组织学活动征象的相关性。
Clin Nephrol. 1982 Nov;18(5):230-9.
5
Similar disturbances in B cell activity and regulatory T cell function in Henoch-Schönlein purpura and systemic lupus erythematosus.过敏性紫癜和系统性红斑狼疮中B细胞活性及调节性T细胞功能的类似紊乱
J Immunol. 1982 Jan;128(1):486-91.
6
Lymphocyte subpopulations in anaphylactoid purpura.过敏性紫癜中的淋巴细胞亚群
Arch Dis Child. 1980 Jul;55(7):541-3. doi: 10.1136/adc.55.7.541.
7
IgA-deposits in cutaneous blood-vessel walls and mesangium in Henoch-Schönlein syndrome.过敏性紫癜中皮肤血管壁和系膜中的IgA沉积。
Lancet. 1973 Apr 21;1(7808):892-3. doi: 10.1016/s0140-6736(73)91471-2.
8
Incidence of renal complications in Schönlein-Henoch purpura syndrome in dependence of an early administration of steroids.
Int Urol Nephrol. 1988;20(4):409-12. doi: 10.1007/BF02549574.
9
Mechanism of action of glucocorticosteroids. Inhibition of T cell proliferation and interleukin 2 production by hydrocortisone is reversed by leukotriene B4.糖皮质激素的作用机制。白三烯B4可逆转氢化可的松对T细胞增殖和白细胞介素2产生的抑制作用。
J Clin Invest. 1986 Apr;77(4):1244-50. doi: 10.1172/JCI112427.
10
Prophylaxis and therapy of glomerulonephritis in the course of anaphylactoid purpura. The results of a polycentric clinical trial.过敏性紫癜病程中肾小球肾炎的预防与治疗。一项多中心临床试验的结果。
Acta Paediatr Scand. 1990 Oct;79(10):976-7. doi: 10.1111/j.1651-2227.1990.tb11365.x.